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Abstract Nonstructural protein 1 (NS1) is a non-struc-
tural protein of avian influenza virus. It can interact with a
variety of proteins of the host cells, enhancing the
expression of viral proteins and changing the growth and
metabolism of the host cells, thereby enhancing the virus’
pathogenicity and virulence. To investigate whether there
are more host proteins that can interact with NS1 during
viral infection, T7-phage display system was used to screen
human lung cell cDNA library for proteins that could
interact with NS1. One positive and specific clone was
obtained and identified as nucleolar and coiled-body
phosphoprotein 1(NOLC1). The interaction between these
two proteins was further demonstrated by His-pull-down
and co-immunoprecipitation experiments. Co-expression
of both proteins in HeLa cell showed that NS1 and NOLC1
were co-localized in the cell’s nucleus. Gene truncation
experiments revealed that the effector domain of NS1 was
sufficient to interact with NOLC1. The results demon-
strated a positive interaction between a viral NS1 and
NOLC1 of the host cells, and provided a new target for
drug screening.
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Introduction
The recent emergence of highly pathogenic avian influenza
viruses (H5N1) have raised significant global health con-
cerns because of the epizootic and panzootic nature of
these viruses, as well as their association with lethal human
infections [1, 2]. Influenza virus contains eight RNA seg-
ments, the eighth of which encodes two proteins: NS1
(nonstructural protein 1) and NS2/NEP (nonstructural
protein 1/nuclear export protein). NS1 is a multifunctional
protein of 202–237 amino acids with a molecular weight of
about 28 kDa that is translated from unspliced mRNA [3,
4]. Two functional domains have been identified in the NS1
protein: N-terminal RNA binding domain (RBD, 1–73 aa)
and C-terminal effector domain (ED, 74–230/237 aa) [5–
7]. These two domains function in viral infection through
protein-RNA and protein–protein interactions with double-
stranded RNA and certain viral proteins [8, 9]. NS1 protein
is a multifunctional regulatory protein and plays an
important role in regulating the pathogenicity and virulence
of the avian influenza virus [10, 11]. NS1 interacts with a
variety of host proteins in the cells, including Staufen
protein, eukaryotic translation initiation factor 4GI
(eIF4GI), NS1 binding factor (NS1-I), poly (A) binding
protein I (PABPI), and P85b protein [12–16]. Through
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protein–protein interaction, NSl protein can reinforce the
transcription and translation of viral mRNA, inhibit the
synthesis of host protein, change the distribution of host
proteins, and restrain production of interferon. It can also
reduce the host’s apoptosis and anti-virus capabilities, and
promote the replication and release of virus particles.
Therefore, research on the interaction between NSl and
host proteins is expected to further reveal the role of NSl in
AIV pathogenesis.
In order to find more host proteins that interact with NS1,
T7-phage display system was used to screen a lung cell
cDNA library for potential NS1-interacting protein. One of
the positive clones obtained from this experiment was
identified as nucleolar and coiled-body phosphoprotein
1(NOLC1), which is a highly phosphorylated protein that
exists in the interphase of the nucleolus [17] and can bind to
RNA polymerase I to regulate the transcription of rRNA
during mitotic division. NOLC1 plays an important role in
the regulation of cell growth, inflammation genesis, and
hepatoma development [18]. Co-immunoprecipitation and
His-pull experiments were used to further investigate the
interaction between NS1 and NOLC1. In addition, fusion
proteins consisting of NS1-green fluorescent protein and of
NOLC1-red fluorescent protein co-expressed in HeLa cells
were found to be co-localized in the nucleus. Furthermore,
gene truncating experiments revealed that the effector
domain of NS1 was sufficient to interact with NOLC1. This
study lays the foundation for furthering our understanding of
the interaction between NS1 and host cells, and the replica-
tion mechanism of avian influenza virus in the host cells.
Given the important roles of NOLC1, this finding also pro-
vides a potential target for anti-influenza drug design. This
would be particularly relevant for prophylaxis and treatment
in the event of an emerging influenza virus outbreak.
Materials and methods
Materials
Cell lines, vectors, bacterial strains
A/Goose/Guangdong/1/96 H5N1 influenza virus and
human embryonic kidney cell line 293T cells were
obtained from a culture stored in the State Key Laboratory
of virology of Wuhan University. pET-28a plasmid,
pCMV-flag plasmid, E. coli DH5a, and E.coli BL21
competent cells were maintained in our laboratory.
Reagents
DNA Marker DL2000, restriction enzymes EcoRI and
BamHI were purchased from Takara. Protein marker was
purchased from MBI. High purity plasmid (small) extrac-
tion kit was purchased from Beijing Union International
Biological Gene Inc; isopropyl-b-D-thiogalactopyranoside
(IPTG) was purchased from Beijing Bio-Tech Gene
Technology LLC. Ni–NTA His-bind Resins were obtained
from Novagen Inc. LipofectamineTM 2000 was purchased
from Invitrogen Corporation. PMSF (protease inhibitor)
was purchased from Amersco Corporation. Protease
cocktail was obtained from Merck Corporation; Protein
A/G-plus-Agarose beads from Promega Company; OctA-
Probe antibody from Santa Cruz Corporation; MagneHisTM
Protein Purification System from promega; Horseradish
peroxidase labeled secondary antibody from Beijing
Zhongshan Golden Bridge Company; and Western blotting
Luminol Reagent test kit from Santa Cruz Corporation.
Methods
Screening of NS1-interacting host protein using T7-phage
display system
The pET-28a-NS1 construct was made by inserting the
corresponding cDNA fragment derived from the A/Goose/
Guangdong/1/96 H5N1 influenza virus into the BamHI/
EcoRI sites of pET-28a. The recombinant NS1 was
expressed in E. coli BL21(DE3). After expression the cells
were harvested, 5 mL solution A (10 mmol/L Tris–HCl,
pH 8.0), 20–30 mL binding buffer containing 10 mmol/L
imidazole, 1.5 mL of 100 lg/mL lysozyme, and 30 lL of
1 mmol/L PMSF were added to the cells and mixed ad
subjected to two freeze/thaw cycles at -70 C/room tem-
perature. The cells were disrupted by an ultrasonic cell
disruptor (200–300 W output power) while being kept in
an ice bath. After centrifugation (10,0009g, 15 min), the
NS1 protein in the supernatant was purified by Novagen
Ni–NTA His-bind Resins as described previously [19].
Microtiter plate wells were coated with 1 lg NS1 protein
dispensing 100 lL PBS containing 0.01 lg/mL NS1 onto
each well and the plate was incubated at 4 C for over-
night. Human liver cell cDNA Phage library was added and
incubated for 2 h at RT. After washing with PBS con-
taining 0.1 % Tween 20 for 10 times, the adsorbed phage
particles were eluted with 1 % SDS solution and then
amplified by infection of E.coli BLT5403 to generate sub-
libraries. This binding-elution-amplification procedure was
repeated 3–5 rounds until the eluted phage titer was sta-
bilized at a certain titer. After round 5, 24 positive plaques
were randomly picked, the phage genome was extracted,
and the inserted segment of the phage DNA was amplified
by PCR using T7 select up and down primers. The
amplified products were detected by 1 % agarose gel
electrophoresis, purified and subjected to DNA sequencing.
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The DNA sequences obtained were analyzed by blast in
NCBI.
Affinity-binding assays by co-immunoprecipitation (Co-IP)
The recombinant plasmids pEGFP-N1-NS1 and pCMV-
flag-NOLC1 were constructed and co-transfected into 293T
cells. After 48 h, the transfected cells were collected and
washed three times in PBS, harvested by scraping, and
centrifuged for 5 min at 5009g. The cell pellet was
homogenized at 4 C by pipetting up and down with 1 mL
of cell lysis buffer. The homogenate was centrifuged at
14,0009g for 20 min at 4 C, and the supernatant was
incubated with 5 lL of anti-FLAG polyclonal antibody and
20 lL protein A/G-plus beads for overnight at 4 C. The
resins were recovered by centrifugation at 7009g for 5 min
and washed three times with cell lysis buffer followed by
centrifugation after each wash. The pellet was then washed
twice with 50 mM Tris–HCL (pH 7.5) containing 0.1 %
(w/v) SDS and 150 mM NaCl. After the final wash, it was
resuspended in 60 lL 19 SDS loading buffer, heated at
100 C for 3 min and subjected to SDS-PAGE followed by
western blot analysis with anti-GFP antibody. As a control,
EGFP-NS1 and pCMV-flag were also co-transfected into
293T cells and subjected to the same experiment.
Affinity-binding assays by pull-down experiment
His-NS1 fusion protein was expressed in E. coli BL21
induced by IPTG. Five milligrams of His-NS1 was adsor-
bed onto MagneHisTM beads, as recommended by the
manufacturer (Promega). The immobilized proteins were
mixed with 200 lL of 293T cell extracts containing flag-
tagged NOLC1 in binding buffer (50 mM Tris–HCl,
150 mM NaCl, 1.0 %Triton X-100, pH 7.6) containing a
protease inhibitor mix (Roche) and incubated for 1 h at
room temperature on a rotator. Beads were precipitated and
washed three times with 500 lL of binding buffer. Proteins
bound to His-tagged-NS1 were analyzed by SDS-PAGE,
followed by western blot analysis with anti-flag antibody.
Subcellular localization by confocal microscopy
The recombinant plasmids pEGFP-N1-NS1 and pDsRed-
C1-NOLC1 were constructed and co-transfected into Hela
cells at a ratio of 1:3 for pEGFP-N1-NS1: pDsRed-C1-
NOLC1 using LipofectamineTM 2000. For controls, pDs-
Red-C1 and pEGFP-N1 were co-transfected into Hela cells
instead. The transfected cells were grown on glass cover-
slips. Two days after transfection, the cells were fixed with
4 % paraformaldehyde in phosphate-buffered saline (PBS)
for 20 min at room temperature and the nuclei were stained
with DAPI. The distribution and localization of the green
fluorescence, red fluorescence, and the cell nuclei were
observed by confocal microscope.
Identification of interaction domains by gene truncation
and co-immunoprecipitation
In order to locate the region of NS1 that interact with the
protein identified from the host cells, eukaryotic expression
vectors pEGFP-N1-NS1-RBD(1–73 aa) and pEGFP-N1-
NS1-ED(74–230 aa), which express the N-terminal RNA
binding domain and C-terminal effector domain of NS1
protein, respectively, were constructed. The protein–protein
interactions between truncated NS1 and NOLC1 were
investigated by co-immunoprecipitation as described above.
Results
Phage display screening
Escherichia coli BL21 strain harboring pET-28a-NS1 was
cultured and induced by IPTG to express NS1 protein. Cell
extract was prepared and soluble proteins of the extract were
collected and subjected to SDS-PAGE analysis. A specific
band corresponding to 28 kDa was detected in the gel
(Fig. 1). In order to screen the proteins that interact with
NS1, five rounds of bio-screening were performed. The titers
of phages that bound to NS1 increased after each round of
screening, which suggested that clones of higher affinity
were enriched. Overall, 104-fold increase in recovery rate
was obtained after five rounds of screening. Twenty-four
plaques were randomly selected from the fifth round of
screening and the inserted segment was sequenced and
blasted against NCBI database. The results showed that the
protein that interacted with NS1 was the Human NOLC1.
Interaction between NS1 and NOLC1 as determined
by immunoprecipitation
We further confirmed the interaction between NOLC1
and NS1 using immunoprecipitation. The expression





Fig. 1 SDS-PAGE analysis of purified NS1. Expression of NS1 by
E. coli BL21(DE3) harboring pET-28a-NS1 was induced by 1 mmol/
L IPTG. The cells were harvested, and soluble fraction of the lysate
was subjected to protein purification via Novagen Ni–NTA His-bind
Resins and the purified protein was analyzed by SDS-PAGE. M,
Protein Marker; lane 1, Purified NS1
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co-transfected into 293T cells. Twenty-four hours after
transfection the cell extracts were prepared and subjected
to immunoprecipitation with anti-flag antibody. The pre-
cipitated proteins were analyzed by western blot with
anti-GFP antibody. The results showed that NOLC1 was
associated with NS1 protein. However, no band was detected
when cells expressed NS1 without NOCL1 (Fig. 2).
NS1 and NOLC1 interaction determined by pull-down
assay
Pull-down was also performed to further confirm the
interaction between NOLC1 and NS1. The His-NS1 fusion
protein expressed in E. coli BL21 were adsorbed to
MagneHisTM beads and then incubated with the lysate of
293T cell overexpressing Flag-NOLC1 fusion protein.
Proteins bound to His-NS1 were analyzed by western blot
with anti-flag antibody, and a band at approximately 130
kD was detected as expected. This band was not detected in
the negative control, in which lysate of 293T cells over-
expressing Flag-NOLC1 fusion protein was incubated with
just MagneHisTM beads (Fig. 3).
Co-localization of NOLC1 and NS1 proteins
Based on the results above, we hypothesized that the
interaction between NOLC1 and NS1 is physiologically
relevant, so we expected the two proteins to occupy the
same intracellular compartment. To confirm this predic-
tion, DsRed-NOLC1 and EGFP-NS1 fusion proteins were
co-expressed in HeLa cells. EGFP-NS1 fusion protein was
mainly localized in the nucleus but a small amount of it
was also distributed in the cytoplasm, whereas DsRed-
NOLC1 protein was localized only in the nucleolus. The
results showed that NS1 and NOLC1 were co-localized in
the nuclear compartment (Fig. 4).
Identification of interaction domains
Nonstructural protein 1 consists of two major domains, the
N-terminal RNA binding domain (RBD) and the remaining
effector domain (ED). In order to determine which domain
of NS1 interacts with NOLC1, each of the two domains of
NS1 were separately constructed and expressed followed
by Co-IP analysis. The results showed that the effector
domain of the NS1 was the domain that interacted with
NOLC1 (Fig. 5).
Discussion
NS1 is one of the known non-structural proteins encoded
by the avian influenza virus that plays an important role in
the regulation of the pathogenicity and virulence of influ-
enza virus; it might be the key to the high mortality rate
associated with avian influenza. As a multifunctional pro-
tein, NS1 can interact with a variety of host cell proteins to
weaken the host’s antiviral resistance and strengthen the
virus’ propagation. Previous researches have shown that
NS1 can inhibit the expression of host cell proteins, thereby
strengthening the synthesis of viral proteins and inhibiting
the production of interferon. In addition, NS1 protein can
regulate the apoptosis of host cells to ensure the virus’
efficient replication in the cells [20]. In depth study of NS1
not only allows us to better understand the interaction
between the host cell and the virus, but also provides us
with a theoretical basis of the relationship between the NS1
and the virulence of the virus.
In this study, we found a new protein that interact with
NS1 through T7-phage display technology, and identified it
as NOLC1, which was previously named as Nopp140 or
p130. Co-IP and His-pull-down experiments confirmed the
specific interaction between these two proteins. NOLC1
protein is a highly phosphorylated protein that exists in the
interphase nucleolus [17]. It can itself distribute uniformly
in cytoplasm, and function both as a chaperone that shuttles
pEGFP-N1-NS1
pCMV-flag- -








Fig. 2 Interaction between NS1 and NOLC1 as determined by
immunoprecipitation. pEGFP-N1-NS1 and pCMV-flag-NOLC1 were
co-transfected into the 293T cells, and the cell lysate were subjected
to immunoprecipitation with anti-FLAG polyclonal antibody. The
immunoprecipitated proteins were detected by western blot with anti-
GFP antibody. Lane 1, NS1 as detected by western blot with anti-GFP
antibody; lane 2 and lane 3, IP performed with the appropriate
transfection as indicated followed by western blot. Beta-actin was




Fig. 3 NS1 and NOLC1 interaction determined by pull-down assay.
Lane 1, Lysate from 293T cells expressing flag-NOLC1was subjected
to direct western blot with anti-flag anitbody. Lysate from 293T cells
expressing flag-NOLC1was incubated with His-tagged NS1-Magne-
HisTM beads (lane 2) or just MagneHisTM beads (lane 3) followed by
western blot of the bead-bound proteins with anti-flag antibody
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between the nucleolus and cytoplasm, as well as a regulator
which binds to RNA polymerase I to regulate the tran-
scription of rRNA during mitotic division. NOLC1 is
thought to be involved in the activation carried out within
the nucleolus. It is also a mediator of protein kinase A
signaling pathway that activates the acute phase response
a1_acid glycoprotein gene [21]. Recent results have shown
that NOLC1 may play an important role in the regulation of
cell growth, inflammation genesis, and hepatoma devel-
opment [18]. It plays a role in the regulation of tumori-
genesis of nasopharyngeal carcinoma progression (NPC),
both NOLC1 and tumor protein 53 work in synergism to
activate the MDM2 promoter in NPC cells [22]. These
observations suggested that NOLC1 was crucial for normal
Fig. 4 Subcellular localization of NOLC1 and NS1. HeLa cells were
co-transfected with NOLC1-DsRed and NS1-EGFP (a, b, c) or with
DsRed and EGFP only (d, e). Cells were detected by green
fluorescence (a, d), red fluorescence (b, e), or DAPI staining, and
the image of which was merged with those of a and b (c) (Color figure
online)
pEGFP-N1-NS1(RBD) + +
pCMV-flag-NOLC1      - +
pCMV- -
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Fig. 5 Interaction between domain of NS1 and NOLC1. pEGFP-N1-
NS1-RBD and pEGFP-N1-NS1-ED, which express the N-terminal
RNA binding domain and C-terminal effector domain of NS1,
respectively, were coexpressed with NOLC1 in 293T cells. The
protein–protein interactions between truncated NS1 proteins and
NOLC1 were investigated by coimmunoprecipitation followed by
western blot. a RBD domain plus NOLC1. Lane 1, NOLC1and RBD
as determined by IP and western blot; lane 2, Input of RBD (western
blot only); lane 3, GFP and RBD as determined by IP and western
blot. b ED domain plus NOLC1. Lane 1, NOLC1 and ED as
determined by IP and western blot; lane 2, Input of ED (western blot
only); lane 3, GFP and ED as determined by IP and western blot.
Beta-actin was detected using a whole cell lysate
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cell growth. So we proposed that when the influenza virus
infects the host cells and express its protein, the NS1 will
bind to and inactivate NOLC1, losing a crucial protein for
its normal cell growth, and at the same time undergo
apoptosis. That is one way through which the cell can resist
viral infection.
Our study also showed that NS1 was mainly localized in
the nucleus, while DsRed-NOLC1 was localized only in
the nucleolus. The two proteins occupied the same intra-
cellular compartment, suggesting that the interaction
between NOLC1 and NS1 was physiologically relevant. To
further investigate the interaction of these two proteins, the
domain of NS1 that was involved in the interaction with
NOLC1 was mapped through gene truncation experiment,
which identified the effector domain (ED) as the domain
that interacted with the NOLC1. The ED interacts with
cellular targets such as Staufen protein, eukaryotic trans-
lation initiation factor 4GI (eIF4GI), NS1-I, PABPI, and
P58b protein, and contributes to the virulence of AIV. Our
results have shed more light into the function of the
effector domain of NS1. Future work will attempt to
indentify the specific region within the effector domain that
interacts with NOLC1 through additional gene truncation
as well as point mutation aiming to provide a new target
spot for the screening of anti-viral drugs. Further investi-
gation will also be carried out to examine the effect of the
interaction between NOLC1 and NS1 on the functional
activity of host cells and the cell cycle, which will provide
the theoretical basis for better understanding of the func-
tion of NS1 and the mechanism associated with the path-
ogenesis of AIV.
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